4
Changes in Ownership
Benitec Biopharma Inc. Filed Acc 0000899140-25-001479
Director bought 144,223 shares at an average $13.20 ($1,903,133)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC Director | 2025-12-23 | Purchase | +42,600 | $12.85 | $547,410 | 9,620,075 | I |
| SUVRETTA CAPITAL MANAGEMENT, LLC Director | 2025-12-23 | Purchase | +7,400 | $12.85 | $95,090 | 1,834,053 | I |
| SUVRETTA CAPITAL MANAGEMENT, LLC Director | 2025-12-26 | Purchase | +14,320 | $13.10 | $187,592 | 9,634,395 | I |
| SUVRETTA CAPITAL MANAGEMENT, LLC Director | 2025-12-26 | Purchase | +2,516 | $13.10 | $32,960 | 1,836,569 | I |
| SUVRETTA CAPITAL MANAGEMENT, LLC Director | 2025-12-29 | Purchase | +65,800 | $13.44 | $884,352 | 9,700,195 | I |
| SUVRETTA CAPITAL MANAGEMENT, LLC Director | 2025-12-29 | Purchase | +11,587 | $13.44 | $155,729 | 1,848,156 | I |
| Open-market purchases · 144,223 sh · avg $13.20 · $1,903,133 | |||||||
Loading xslF345X05/form4.xml…